Atorvastatin decreases serum levels of advanced glycation...

Atorvastatin decreases serum levels of advanced glycation endproducts (AGEs) in nonalcoholic steatohepatitis (NASH) patients with dyslipidemia: clinical usefulness of AGEs as a biomarker for the attenuation of NASH

Yuki Kimura, Hideyuki Hyogo, Sho-ichi Yamagishi, Masayoshi Takeuchi, Tomokazu Ishitobi, Yoshitaka Nabeshima, Koji Arihiro, Kazuaki Chayama
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
45
Language:
english
Pages:
8
DOI:
10.1007/s00535-010-0203-y
Date:
July, 2010
File:
PDF, 202 KB
english, 2010
Conversion to is in progress
Conversion to is failed